Streptozotocin
(I)1', the only known naturally occurring N-methyl-N-nitrosourea derivative, is elaborated by Streptompces achromogenes var. streptozoticus'). Its diabetogenic action, its use as an antiinsulinoma and antileukemia agent as well as its carcinogenicity have recently been reviewed').
Our general interest in the unexplored area of biochemical nitrogen-nitrogen bond formation and our specific interest in the biosynthesis of antibiotics that contain a nitrogen-nitrogen bond (cf ref. Method B. Seed medium"' consisting of (g/liter) cotton seed meal, 25 and Cerelose, 25, in 25 nil distilled w~.ter in 125-nil Erlenmeyer flasks was inoculated with 0.1 nil of spore suspension of S. achrornogenes and shaken for 4080 hours at 27-C at 250 rpm. The resulting mycelial suspension (1.5 nil) was transferred into 500-m1 Erlenmeyer flasks containing 100m] of production medium having the composition given under Method A except that 14 g/liter (NH.i)2SO, was used instead of only 4 g/liter and that the glucose was reduced to I g/liter. The cultures were shaken at 350 rpm at 28'C for 5 days, radioactive precursors and/or other supplements were added 24 hours before isolating streptozotocin by the acetone precipitation procedure. The resulting solution was concentrated to approximately one nil anc chromatographed on a column of Sephadex G-10 (10x0.5 cni) using water as the eluant. The elution was monitored by spotting small aliquots of the column fractions on paper followed by spraying with the spray reagent given above. The pooled fractions were concentrated to a small volume and the antibiotic was subjected to paper chromatography in acetone -water (85: 15). The streptozotocin zone was eluted with water and further purified by paper chromatography in 1-butanol -acetic acid -water (2: 1 : 1) yielding a homogeneous sample of the antibiotic after its elution with water. The aqueous solutions obtained were either freeze dried or kept frozen. were suspended in H2O (1.4 ml), covered with ether (50 ml) and then treated with 2 N NaOH (1.5 ml) at O,C for 10 minutes yielding compound 1112) and diazomethane which was trapped with 250 mg of p-nitrobenzoic acid dissolved in 60 ml of ether as p-nitrobenzoic acid methyl ester whose specific radioactivity was determined. Treatment of compound 11 remaining in the reaction vessel with 2 N HCI (3 nil) for 45 minutes at room temperature yielded glucosamine III, and CO2. The latter was trapped in a saturated solution of barium hydroxide.
The precipitate of barium carbonate formed was isolated by filtration, washed with water, dried, weighed and the radioactivity was counted in Triton-EDTA by the method of LARSEN"). o-Glucosamine remaining in the reaction flask was isolated and purified by preparative paper chromatography in methanol -1-butanol -water -conc. ammonia (80: 20: 10: 3) Rf= 0.65, followed by elution from the paper with water and subsequent recrystallization to constant specific radioactivity from water -acetone. In this instance the tritium incorporation is given. 6 Subjected to chemical degradation , see Table 2 . 4 g/liter, was optimal for pH control. Ammonium sulfate was recommended by previous workers') to maintain the pH of the fermentation at pH 4-5, the pH range of optimal stability of streptozotocin, and it was assumed that selective utilization of the ammonium by the culture was responsible for the pH controlling effect. We have measured the levels of streptozotocin, glucose and ammonium as well as the pH in the fermentation and find that while the streptozotocin titre rises to a peak of 70 mg in 14 days, which is higher than any previously reported streptozotocin titre, that glucose is utilized completely during the first 24-hour period after inoculation and that the ammonium level and the pH remain essentially constant (data not shown). Attempts to achieve stabili- Table 3 .
It is evident from the results of our feeding experiments with the precursors listed in Table   1 and from the results of the chemical degradations (Table 2) , which were carried out by the sequence of reactions shown in Fig. 1 The demonstration that D- [1-19C, 6 -3H]glucosamine and L-[ureido-14C]citrulline are specific precursors of streptozotocin suggests that N(a) and N(b), respectively, of the antibiotic may be provided by these precursors as outlined in Fig. 2 . If this assumption could be substantiated then it should be possible to saturate these two nitrogen atoms by feeding a suitable excess of D-glucosamine and zotocin were synthesized, it is conceivable that the dilution is due entirely to streptozotocin that had been produced prior to the addition of the precursors. This would mean that the added pre- to donate the intact carbamoyl group in that pathway'" . In both the streptozotocin and the mitomycin pathway it is possible that the carbamoyl group of the citrulline ureido group is transferred directly to an appropriate acceptor, or that carbarnoyl phosphate is involved as an intermediate, which could be formed via a reversal of the ornithine transcarbarnoylase reaction. Arginine could feed into these pathways after its conversion into citrulline by the action of the enzyme arginine deiminase.
Low levels of this enzyme have been demonstrated in mitomycin-producing Streptomjces verticillatus from which an arginine deiminase activity has been enriched nearly 50 fold and also S. achromogenes var. streptozotictis crude-cell-free extracts were shown to have low levels of this activity (J. H. EGGERT, T. J. SMITH, M. R. DHAWALE , and U. HORNEMANN, unpublished observations).
The very efficient utilization of D-glucosamine and of L-citrulline in the dilution experiments reported in Table 3 is of great interest. Two possible explanations for this efficient utilization may be considered:
(1) the existence of very efficient uptake systems for both precursors and (2) the possible existence of membrane bound enzymes involved in the streptozotocin pathway or even the existence of exoenzymes. If the latter possibility were used by S. aclnromogenes var. streptoroticas then a mechanism would exist to prevent the highly mutagenic antibiotic from damaging the DNA of the producing organism.
